rs142775522

Variant summary

Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2

The NM_003126.4(SPTA1):​c.6672A>C​(p.Glu2224Asp) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000898 in 1,614,124 control chromosomes in the GnomAD database, including 10 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.0046 ( 4 hom., cov: 32)
Exomes 𝑓: 0.00051 ( 6 hom. )

Consequence

SPTA1
NM_003126.4 missense

Scores

2
4
10

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts P:1B:5

Conservation

PhyloP100: 0.202
Variant links:
Genes affected
SPTA1 (HGNC:11272): (spectrin alpha, erythrocytic 1) This gene encodes a member of a family of molecular scaffold proteins that link the plasma membrane to the actin cytoskeleton and functions in the determination of cell shape, arrangement of transmembrane proteins, and organization of organelles. The encoded protein is primarily composed of 22 spectrin repeats which are involved in dimer formation. It forms a component of the erythrocyte plasma membrane. Mutations in this gene result in a variety of hereditary red blood cell disorders, including elliptocytosis-2, pyropoikilocytosis, and spherocytosis, type 3. [provided by RefSeq, Aug 2017]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.0067679286).
BP6
Variant 1-158615332-T-G is Benign according to our data. Variant chr1-158615332-T-G is described in ClinVar as [Likely_benign]. Clinvar id is 258956.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population afr. gnomad4 allele frequency = 0.00461 (703/152330) while in subpopulation AFR AF= 0.0163 (676/41580). AF 95% confidence interval is 0.0152. There are 4 homozygotes in gnomad4. There are 334 alleles in male gnomad4 subpopulation. Median coverage is 32. This position pass quality control queck.
BS2
High Homozygotes in GnomAd4 at 4 AD,AR gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
SPTA1NM_003126.4 linkc.6672A>C p.Glu2224Asp missense_variant Exon 48 of 52 ENST00000643759.2 NP_003117.2 P02549-1
SPTA1XM_011509916.3 linkc.6672A>C p.Glu2224Asp missense_variant Exon 49 of 53 XP_011508218.1 P02549-1
SPTA1XM_011509917.4 linkc.6654A>C p.Glu2218Asp missense_variant Exon 47 of 51 XP_011508219.1
SPTA1XM_047428883.1 linkc.6351A>C p.Glu2117Asp missense_variant Exon 48 of 52 XP_047284839.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
SPTA1ENST00000643759.2 linkc.6672A>C p.Glu2224Asp missense_variant Exon 48 of 52 NM_003126.4 ENSP00000495214.1 P02549-1
SPTA1ENST00000492934.1 linkn.187A>C non_coding_transcript_exon_variant Exon 3 of 3 2
SPTA1ENST00000498708.1 linkn.104A>C non_coding_transcript_exon_variant Exon 2 of 5 3

Frequencies

GnomAD3 genomes
AF:
0.00458
AC:
697
AN:
152212
Hom.:
4
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0162
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00124
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.000207
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000294
Gnomad OTH
AF:
0.00239
GnomAD3 exomes
AF:
0.00111
AC:
278
AN:
249558
Hom.:
0
AF XY:
0.000835
AC XY:
113
AN XY:
135396
show subpopulations
Gnomad AFR exome
AF:
0.0153
Gnomad AMR exome
AF:
0.000985
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad SAS exome
AF:
0.0000654
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.0000177
Gnomad OTH exome
AF:
0.000495
GnomAD4 exome
AF:
0.000510
AC:
746
AN:
1461794
Hom.:
6
Cov.:
31
AF XY:
0.000446
AC XY:
324
AN XY:
727196
show subpopulations
Gnomad4 AFR exome
AF:
0.0178
Gnomad4 AMR exome
AF:
0.000939
Gnomad4 ASJ exome
AF:
0.00
Gnomad4 EAS exome
AF:
0.00
Gnomad4 SAS exome
AF:
0.000104
Gnomad4 FIN exome
AF:
0.00
Gnomad4 NFE exome
AF:
0.0000243
Gnomad4 OTH exome
AF:
0.00103
GnomAD4 genome
AF:
0.00461
AC:
703
AN:
152330
Hom.:
4
Cov.:
32
AF XY:
0.00448
AC XY:
334
AN XY:
74494
show subpopulations
Gnomad4 AFR
AF:
0.0163
Gnomad4 AMR
AF:
0.00124
Gnomad4 ASJ
AF:
0.00
Gnomad4 EAS
AF:
0.00
Gnomad4 SAS
AF:
0.000207
Gnomad4 FIN
AF:
0.00
Gnomad4 NFE
AF:
0.0000294
Gnomad4 OTH
AF:
0.00236
Alfa
AF:
0.000689
Hom.:
2
Bravo
AF:
0.00480
ESP6500AA
AF:
0.0137
AC:
55
ESP6500EA
AF:
0.00
AC:
0
ExAC
AF:
0.00132
AC:
160
Asia WGS
AF:
0.000289
AC:
1
AN:
3478
EpiCase
AF:
0.0000545
EpiControl
AF:
0.00

ClinVar

Significance: Benign/Likely benign
Submissions summary: Pathogenic:1Benign:5
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:3
Apr 01, 2022
CeGaT Center for Human Genetics Tuebingen
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

SPTA1: BP4, BS1, BS2 -

Dec 17, 2024
Labcorp Genetics (formerly Invitae), Labcorp
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

Mar 31, 2022
ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories
Significance: Likely benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

Familial hemolytic anemia Pathogenic:1
Feb 27, 2018
Department of Genetic, Henri Mondor Hospital, Assistance Publique des Hôpitaux de Paris
Significance: Likely pathogenic
Review Status: flagged submission
Collection Method: clinical testing

- -

Elliptocytosis 2 Benign:1
Jan 13, 2018
Illumina Laboratory Services, Illumina
Significance: Likely benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as likely benign is not then subjected to further curation. The score for this variant resulted in a classification of likely benign for this disease. -

not specified Benign:1
-
PreventionGenetics, part of Exact Sciences
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Uncertain
0.39
BayesDel_addAF
Benign
-0.37
T
BayesDel_noAF
Benign
-0.29
CADD
Benign
16
DANN
Uncertain
1.0
DEOGEN2
Benign
0.40
T;T
Eigen
Benign
-0.020
Eigen_PC
Benign
-0.17
FATHMM_MKL
Uncertain
0.85
D
LIST_S2
Pathogenic
0.99
.;D
MetaRNN
Benign
0.0068
T;T
MetaSVM
Benign
-0.78
T
MutationAssessor
Uncertain
2.8
M;M
PrimateAI
Benign
0.43
T
REVEL
Benign
0.22
Sift4G
Pathogenic
0.0
D;.
Polyphen
1.0
D;D
Vest4
0.74
MutPred
0.37
Gain of helix (P = 0.1736);Gain of helix (P = 0.1736);
MVP
0.65
MPC
0.22
ClinPred
0.030
T
GERP RS
-0.25
Varity_R
0.43
gMVP
0.37

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs142775522; hg19: chr1-158585122; API